It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Psychiatric symptoms are common in neurodevelopmental movement disorders, including some types of dystonia. However, research has mainly focused on motor manifestations and underlying circuits. Myoclonus-dystonia is a rare and homogeneous neurodevelopmental condition serving as an illustrative paradigm of childhood-onset dystonias, associated with psychiatric symptoms. Here, we assessed the prevalence of psychiatric disorders and the severity of depressive symptoms in patients with myoclonus-dystonia and healthy volunteers (HV). Using resting-state functional neuroimaging, we compared the effective connectivity within and among non-motor and motor brain networks between patients and HV. We further explored the hierarchical organization of these networks and examined the relationship between their connectivity and the depressive symptoms. Comparing 19 patients to 25 HV, we found a higher prevalence of anxiety disorders and more depressive symptoms in the patient group. Patients exhibited abnormal modulation of the cerebellum on the cerebral cortex in the sensorimotor, dorsal attention, salience, and default mode networks. Moreover, the salience network activity was directed by the cerebellum in patients and was related to depressive symptoms. Altogether, our findings highlight the role of the cerebellar drive on both motor and non-motor cortical areas in this disorder, suggesting cerebellar involvement in the complex phenotype of such neurodevelopmental movement disorders.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Sorbonne University – ICM, Inserm CNRS, Paris Brain Institute, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Neurology, Clinical Investigation Center for Neurosciences, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058); Saint-Antoine Hospital, Department of Neurophysiology, Paris, France (GRID:grid.412370.3) (ISNI:0000 0004 1937 1100)
2 Sorbonne University – ICM, Inserm CNRS, Paris Brain Institute, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Sorbonne Université, UMR S 975, CNRS UMR 7225, ICM, Centre de NeuroImagerie de Recherche (CENIR), Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657)
3 Sorbonne University – ICM, Inserm CNRS, Paris Brain Institute, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Neurology, Clinical Investigation Center for Neurosciences, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058)
4 St Vincent’s University Hospital Dublin, Department of Neurology, Dublin, Ireland (GRID:grid.412751.4) (ISNI:0000 0001 0315 8143)
5 Sorbonne University – ICM, Inserm CNRS, Paris Brain Institute, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); University of Nottingham, School of Medicine, Nottingham, UK (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868)
6 Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, Department of Neurology, Clinical Investigation Center for Neurosciences, Paris, France (GRID:grid.411439.a) (ISNI:0000 0001 2150 9058)
7 Hospices Civils de Lyon, Pierre Wertheimer Neurological Hospital, Expert Parkinson Center NS-PARK/FCRIN, Department of Neurology, Bron, France (GRID:grid.413852.9) (ISNI:0000 0001 2163 3825); CNRS, UMR 5229, Marc Jeannerod Cognitive Neuroscience Institute, Bron, France (GRID:grid.4444.0) (ISNI:0000 0001 2112 9282); University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine et de Maïeutique Lyon Sud Charles Mérieux, Oullins, France (GRID:grid.7849.2) (ISNI:0000 0001 2150 7757)
8 Universitary Hospital of Strasbourg, Département of Neurology, Strasbourg, France (GRID:grid.412220.7) (ISNI:0000 0001 2177 138X); Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM- U964/CNRS-UMR7104/ University of Strasbourg, Illkirch, France (GRID:grid.420255.4) (ISNI:0000 0004 0638 2716); University of Strasbourg, Fédération de Médecine Translationnelle de Strasbourg (FMTS), Strasbourg, France (GRID:grid.11843.3f) (ISNI:0000 0001 2157 9291)
9 Assistance Publique-Hôpitaux de Paris, Sorbonne Paris Nord, Department of Neurology, Avicenne Hospital, Bobigny, France (GRID:grid.50550.35) (ISNI:0000 0001 2175 4109)
10 Universitary Hospital of Pellegrin, Department of Neuropediatry, Bordeaux, France (GRID:grid.42399.35) (ISNI:0000 0004 0593 7118)
11 Abu Dhabi, United Arab Emirates (GRID:grid.42399.35)
12 Inserm U1094, IRD U270, Univ. Limoges, Department of Neurology CHU Limoges, EpiMaCT - Epidemiology of chronic diseases in tropical zone, Institute of Epidemiology and Tropical Neurology, OmegaHealth, Limoges, France (GRID:grid.9966.0) (ISNI:0000 0001 2165 4861)
13 Tourcoing Hospital, Department of Neurology, Tourcoing, France (GRID:grid.418052.a) (ISNI:0000 0004 0594 3884)
14 Lille, France (GRID:grid.418052.a); University of Lille, CHU Lille, INSERM, Lille Centre of Excellence for Neurodegenerative Diseases (LiCEND), Lille, France (GRID:grid.410463.4) (ISNI:0000 0004 0471 8845)
15 University of Calgary, Department of Clinical Neurosciences, Cumming School of Medicine, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697); University of Calgary, Hotchkiss Brain Institute, Calgary, Canada (GRID:grid.22072.35) (ISNI:0000 0004 1936 7697)
16 Sorbonne University – ICM, Inserm CNRS, Paris Brain Institute, Paris, France (GRID:grid.462844.8) (ISNI:0000 0001 2308 1657); Saint-Antoine Hospital, Department of Neurophysiology, Paris, France (GRID:grid.412370.3) (ISNI:0000 0004 1937 1100)